Introduction {#S1}
============

A considerable proportion of patients with psychotic disorders do not respond fully to antipsychotic agents ([@B1]). As an adjunct treatment, however, cognitive behavioral therapy (CBT) has, to some extent, a favorable effect on psychotic symptoms ([@B2]--[@B7]), awareness of illness, distress, preoccupation, conviction, and behavioral consequences of delusional beliefs ([@B8]--[@B11]). A core component of CBT is based on hypothetical reasoning, which consists of the search for alternative explanations for a given experience ([@B12]). Delusions are associated with low belief flexibility, with most patients unable to spontaneously find alternative explanations for their beliefs ([@B13]). Promoting an alternative hypothesis may reduce their degree of conviction, preoccupation, and distress associated with delusions ([@B14], [@B15]).

Despite an increasing need for trained professionals who are able to deliver CBT for psychotic symptoms in naturalistic settings, studies have emphasized that training opportunities are lacking and that the numbers of qualified therapists are poor ([@B16]--[@B18]). Moreover, most studies in the field have been performed in CBT specialized settings with highly selected patients ([@B19]). A number of preliminary studies have shown, however, that new tools that integrate CBT techniques in game format ([@B20], [@B21]) and some forms of computer-assisted therapy ([@B22]) represent promising treatment for patients with psychotic disorders.

"Michael's game" (MG) (Table [1](#T1){ref-type="table"}) is a hypothetical reasoning training module that promotes the dissemination of CBT (specifically, reasoning training) in natural clinical settings. It is based on CBT of psychotic symptoms ([@B5], [@B23], [@B24]), as described elsewhere ([@B20], [@B21]). The aim of the game is to train people to find alternative hypotheses for a given situation.

###### 

**"Michael's game"**.

  --------------------------------------------------------------------------------------------------------
  **Examples of objectives on the cards**
  Describe a situation before interpretation
  Devise the interpretation of a situation as a hypothesis
  Search for different interpretations of the same situation
  Identify the cognitive and behavioral consequences of the different hypotheses
  Search for a link between the interpretation given for a situation and a personal real-life experience
  Put the hypotheses in hierarchical order in terms of their probability
  Search for arguments for or against a hypothesis
  Think of a way of testing a given hypothesis in reality
  **Examples of cards**
  *A non-psychotic and non-emotional situation card*
  Michael sets two bags of different sizes on each side of a scale
  The big bag has the same weight as the small bag
  Michael is surprised since the two bags are supposed to be filled with cotton
  He thinks that the small bag contains a stone
  *A psychotic card*
  Michael is watching his favorite show on television
  When the show host appears, Michael is so pleased that he bursts out laughing
  The show host and another participant in the show start laughing at the same time
  Michael tells himself: "My joy is contagious"
  --------------------------------------------------------------------------------------------------------

*The game was conceived by two of the authors, Yasser Khazaal and Jerome Favrod. It has been translated into English, French, Spanish, German, and Italian. The game includes non-psychotic, non-emotional cards (1--11); emotional, non-psychotic cards (12--32); and psychotic cards (33 to the end)*.

Two preliminary studies ([@B20], [@B21]) support the possible impact of the game on psychotic symptoms.

Those earlier studies had, however, a number of limitations such as lack of control group, lack of blind assessment, the non-controlled character of the pharmacological treatments, as well as the lack of follow-up measures.

Furthermore, the consistency of the intervention was not controlled by audio recording of the sessions. The study at hand aimed to overcome the weakness of the previous works with more rigorous methods such as a randomized controlled design, blind assessments, sessions recording, and a follow-up assessment.

In the present randomized controlled trial, we hypothesized a more important impact of "treatment as usual + Michael's game" (MG) than of "treatment as usual + waiting list" (TAU) on a measure of psychotic symptoms related to conviction (primary outcome) and possibly on measures of distress, preoccupation, symptom intensity, belief flexibility, cognitive insight, awareness of illness, and actions on beliefs (secondary outcomes).

The aim of the trial is to assess the short-term effect (post-intervention) of MG in comparison to TAU on the primary outcome and on further secondary outcomes. The sustained or long-term effect of the intervention in comparison to TAU was also evaluated 6 months after the post-intervention assessment of the primary and secondary outcomes.

Materials and Methods {#S2}
=====================

Participants were outpatients recruited in psychiatric rehabilitation units and outpatient clinics in Switzerland, France, Monaco, and Italy. Potential participants were identified through systematic screening of medical records. Written informed consent was obtained from all participants. Institutional review boards and the ethical committees in Switzerland, France, and Italy approved the study protocol. The protocol was also made available to all study investigators and was registered (International Standard Randomized Controlled Trial Number Register: ISRCTN37178153)[^1^](#fn1){ref-type="fn"}. The study was carried out from October 2008 to September 2011. The study's duration was longer than initially expected because of a delay in the recruitment process. The study had, however, slightly higher recruitment of participants than first planned (172 rather than 166) and a higher retention rate than originally expected (124 patients assessed at the end point rather than the 94 projected). There were no other deviations from the original study protocol.

Randomization {#S2-1}
-------------

Eligible patients were randomized to either TAU or to MG after providing informed consent. The randomization scheme was generated by using the website [randomisation.com](randomisation.com)[^2^](#fn2){ref-type="fn"} and kept independently by a statistician. The allocation ratio used was one to one. A permuted-block randomization procedure was used with fixed block sizes of four patients, ensuring that the number of subjects in the different groups closely balanced at all times. The study investigators, who were in charge of enrollment, were blinded to the randomization sequence in order to prevent them from predicting patient allocation, thus reducing selection bias. There was no randomization by center.

Assessment procedures {#S2-2}
---------------------

Patients were assessed at baseline (T1); at 3 months, after the end of the MG sessions (T2); and 6 months after the second assessment (T3). Psychologists or psychiatrists made the assessments independently from the therapists, and the game leaders and were not informed of the treatment received by the participants (blind evaluation). The patients were given 40 Swiss francs (approximately 35 Euros or 40 US Dollars) as compensation after each evaluation.

Measures {#S2-3}
--------

-   Mini-international neuropsychiatric interview (MINI) ([@B25]) for psychiatric diagnosis according to the *DSM-IV*.

-   Peters delusions inventory (PDI-21) ([@B26], [@B27]). Multidimensionality of delusions is approached in the PDI-21 by measuring distress, preoccupation, and conviction related to each of 21 stated beliefs on a 5-point Likert scale. Patients with psychotic disorders differ from controls by having higher ratings on distress, preoccupation, and conviction scales ([@B26]). The scales were proposed as a possible measure of change during CBT ([@B26]). Results of preliminary studies ([@B20], [@B21]) showed a treatment × time effect on the scores of the PDI-21.

-   Brief psychiatry rating scale (BPRS) ([@B28]). The following scores were considered: affect, positive symptoms, negative symptoms, resistance, activation ([@B29]), and total score.

-   Beck cognitive insight scale (BCIS) ([@B30], [@B31]). The BCIS is composed of two subscales: self-reflectiveness related to the ability to consider alternate explanations and openness to feedback, and self-certainty related to the degree of certainty and confidence related to beliefs. A BCIS composite index is obtained by subtracting the self-certainty from the self-reflectiveness score. It was hypothesized ([@B32]) that low self-reflectiveness and high self-certainty (low composite index) may constitute a reasoning style that would maintain delusional beliefs.

-   Global assessment of functioning (GAF) scale (DSM-IV).

-   Social and occupational functioning assessment scale (SOFAS).

-   Maudsley assessment of delusions schedule (MADS) ([@B33]). MADS is a standardized interview designed to evaluate the phenomena related to the principal abnormal belief of a patient. In practice, the MADS improves the assessment of the possible impact of the game on specific and individualized aspects of the main delusional idea of each included patient and on measures of belief flexibility specifically linked with the main delusional belief. The following MADS assessments were included in the study:

-   Belief flexibility. As suggested elsewhere ([@B15]), the participants were asked whether or not it was possible that they may be mistaken about their main belief (possibility of being mistaken). They were also presented with a hypothetical scenario, which, if true, would contradict the delusion, and asked how this would change their belief (change conviction). The participants were also asked whether or not anything has happened that goes against the belief and "What would have to happen to make you think that you might be wrong about this belief?" This assessment could be considered as a form of "ability to plan a behavioral experiment."

-   Awareness of illness.

Primary outcome {#S2-4}
---------------

The primary outcome was the change after treatment in the conviction score of the PDI-21.

Secondary outcomes {#S2-5}
------------------

The 16 secondary outcomes included the change in scores on the other two subscales of the PDI-21 (distress and preoccupation), the five subscales of the BPRS, the two subscales of the BCIS, the GAF, the SOFAS, and the five items of the MADS.

Sample size and power {#S2-6}
---------------------

An *a priori* sample size was estimated from a pilot study ([@B21]), using the conviction subscale of the PDI-21 in the calculation. By using the Diggle formula for the sample size calculation in longitudinal data, we found that a sample size of at least 47 persons per group was needed at each study evaluation (error rate of 0.05; statistical power of 0.8).

Inclusion criteria {#S2-7}
------------------

-   Psychotic disorder according to the DSM-IV (diagnostic based on chart review and MINI)

-   Outpatient setting

-   18--65 years old

-   Persistent positive psychotic symptoms at inclusion: BPRS score of ≥3 on at least two items of the positive symptoms BPRS subscale

Exclusion criteria {#S2-8}
------------------

-   Organic brain disease

-   Mental retardation

-   BPRS conceptual disorganization score \>5

-   Prior participation in MG

-   Cognitive therapy of psychotic symptoms at inclusion

Interventions {#S2-9}
-------------

### Michael's Game {#S2-9-1}

Michael's game is a collaborative group game consisting of 80 cards (Table [1](#T1){ref-type="table"}). Each card corresponds to a situation and to objectives that target the ability to reason with hypotheses (see Table [1](#T1){ref-type="table"} for an example of a card). Training group leaders (two per session) direct the game during weekly sessions lasting for about 1 h. Because MG is an 80-card game, the mean number of sessions needed to end the game is not *a priori* fixed. The mean number of sessions needed to end the game was 12.1 (SD = 3.41). The mean participation rate of the participants (number of sessions completed by a participant × 100/total number of sessions needed to complete the program in the same group) was 91.2% (SD = 14.1). These figures are similar to those described in the preliminary reports related to the game ([@B20]). Failure to attend more than three sessions was considered to be MG treatment discontinuation. Participants (in groups of four to eight patients) are led through specific questions to find multiple answers (hypotheses) to the questions and conclusions that Michael draws from the situations that he is confronted with. In other words, participants have to help Michael to find alternatives to the conclusions that he draws from situations described on each card. MG was conceived as a collaborative group card game in order to allow patients to become partners of a fictive character (Michael) and together to interact with cards containing impersonal information that may reflect their own concerns. Participants play together on objectives such as the following: describe the situation reported on a given card, identify Michael's hypothesis, search for different hypotheses that may explain the same situation, report the possible cognitive and behavioral consequences of the different hypotheses, give arguments for or against a given hypothesis, and imagine how to test a given hypothesis in reality. Game directors were psychiatric care workers (nurses: 14, psychologists: 12, psychiatrists: 6) who were specifically trained to deliver MG according to the training model described below.

### Treatment as Usual Plus Waiting List (TAU; Control Condition) {#S2-9-2}

Treatment as usual comprises case management, psychosocial interventions, antipsychotic medication, and outpatient and community follow-up. The patients in the TAU condition had to wait until the end of follow-up before participating in a MG.

The collaborative centers had access to similar pharmacological treatment, psychosocial structures, and level of medical training. Medication was monitored during the study. Chlorpromazine equivalences were calculated for antipsychotic medications according to Woods ([@B34]). Participants from both groups received treatment as usual throughout the entire study period.

Quality assurance {#S2-10}
-----------------

Group directors at each of the 16 collaborative centers (nurses, psychologists, psychiatrists) were trained by the same method: a standardized 1 h presentation and a 1 h training session for the game. Training was directed by one of the game's authors or by one person authorized by the authors for his or her educational qualities and experience in directing the game. Supervision was also offered to game directors by the first author upon request. Sessions were audiotaped (not available for all centers) to check their fidelity to the intervention and were assessed with expected therapist strategies extracted from the collaboration, interpersonal effectiveness, understanding, and guided discovery items of the Haddock scale ([@B35]). Twenty-five randomly selected sessions were assessed. The percentage of items rated as being compliant with the desirable strategies ranged from 72 to 100%.

Statistical analyses {#S2-11}
--------------------

At the patient level, baseline differences were checked between the two study groups, as well as differences between completers and non-completers using *t*-tests, chi-square tests, or Fisher's exact tests where applicable.

The direct effect, or the short-term effect, of treatment on the primary and on the secondary continuous outcomes was evaluated through analyses of covariance (ANCOVAs) by considering outcome values after the intervention at T2 and adjusting for the respective baseline outcomes. The treatment group served as the between-subject factor. These analyses were also controlled for center to correct for a possible cluster effect and for medication. Similarly, the long-term effect at T3 of the intervention was measured by ANCOVAS, using outcome values at T3 and adjusting for the respective baseline outcomes. Finally, categorical MADS variables were analyzed at T2 (short-term effect) and T3 (long-term effect) through logistic regression analyses, with treatment group as the between-subject factor, and were also adjusted for baseline outcomes and controlled for center and medication. The necessary application conditions of all these models were checked and met.

### Adjusting for Multiple Testing {#S2-11-3}

The trial was *a priori* powered for multiple time points at a predefined 0.05 significance level, using PDI-21 conviction as the primary outcome. Therefore, this level of significance was kept when the primary outcome results were interpreted. However, to minimize the chance of spurious results pertaining to the secondary outcomes, we adjusted them for multiple testing by Bonferroni's correction (α ≤ 0.05/16 = 0.0031). All the statistical analyses were performed with the Statistical Package for the Social Sciences (SPSS version 18.0, IBM, Chicago, IL, USA).

### Treatment of Missing Data {#S2-11-4}

Analyses were done on an intention-to-treat basis, whereby all randomized subjects were included. Categorical missing data were imputed using logistic regressions. Quantitative missing data were imputed by the expectation--maximization algorithm, a statistical simulation technique that estimates the averages, the matrix of variance and covariance, and the matrix of correlations. After convergence, missing data are replaced by the estimation obtained and the completed data are then analyzed by the usual methods.

Results {#S3}
=======

After screening and informed consent, 172 patients were included and randomized for study participation (Figure [1](#F1){ref-type="fig"}).

![**CONSORT flow diagram**.](fpsyt-06-00066-g001){#F1}

Baseline characteristics of subjects {#S3-12}
------------------------------------

The mean age of the sample was 37.1 years (SD = 10.4). A high school diploma or a university degree had been attained by 27.1% of participants. Most participants had a diagnosis of schizophrenia (81.4%), were single (78.5%), lived in a private residence (59.3%), and had a disability pension (73.1%). Concurrent psychiatric disorders at inclusion were common \[i.e., substance use (15.6%); anxiety disorders (27.2%)\].

At baseline, the PDI-21 distress score was higher for the MG group than for the TAU group at a trend level (*p* = 0.05). There were no differences in the other main clinical measures (Table [2](#T2){ref-type="table"}).

###### 

**Baseline sociodemographic and clinical characteristics of the participants in the Michael's game (MG) and the treatment as usual (TAU) groups**.

  Baseline variables                                                                            TAU             MG              *p*-Value
  --------------------------------------------------------------------------------------------- --------------- --------------- -----------
  Age                                                                                           37.1 (10.8)     37.0 (10.1)     0.9
  Gender: male                                                                                  67.4            57.0            0.2
  Marital status: single                                                                        77.9            79.1            0.9
  Recruiting regional centers                                                                                                   0.9
   Switzerland                                                                                  47.7            51.2            
   France/Monaco                                                                                39.5            37.2            
   Italy                                                                                        12.8            11.6            
  Highest educational degree obtained                                                                                           0.4
   Primary/grammar school                                                                       43.5            50.6            
   Apprenticeship/professional school                                                           24.7            27.1            
   High school/university                                                                       31.8            22.4            
  Diagnosis                                                                                                                     0.2
   Schizophrenia                                                                                77.9            84.9            
   Other psychotic disorders                                                                    22.1            15.1            
  PDI                                                                                                                           
   Distress                                                                                     21.0 (17.3)     25.3 (16.2)     0.05
   Preoccupation                                                                                21.1 (15.8)     23.9 (14.9)     0.1
   Conviction                                                                                   27.0 (18.3)     29.8 (18.4)     0.1
  BCIS                                                                                                                          
   Self-reflectiveness                                                                          14.4 (5.0)      15.1 (4.6)      0.3
   Self-certainty                                                                               8.4 (3.1)       8.9 (4.1)       0.2
   Composite index                                                                              5.9 (6.3)       6.3 (6.5)       1.0
  MADS: anything against the belief                                                                                             
   Yes answers (%)                                                                              38.4            31.4            0.1
  MADS: possibility of being mistaken                                                                                           
   Yes answers (%)                                                                              57.0            52.3            0.7
  MADS: response to hypothetical contradiction (%)                                                                              
   Dismisses belief                                                                             25.6            12.8            0.2
   Changes conviction                                                                           15.1            15.1            
   Accommodates                                                                                 29.1            30.2            
   Ignores or rejects                                                                           30.2            41.9            
  MADS: ability to plan a behavioral experiment (%)                                                                             
   Able to outline evidence and this outcome logically possible                                 36.0            29.1            0.4
   Able to outline evidence but this outcome logically impossible                               12.8            9.3             
   Unable to outline evidence which would contradict his belief                                 51.2            61.6            
  MADS: awareness of illness (%)                                                                                                
   Accept that has a mental illness or nervous problem which includes delusional belief         66.3            52.3            0.2
   Accept that has a mental illness or nervous problem but does not include delusional belief   19.8            30.2            
   Not ill                                                                                      14.0            17.4            
  BPRS                                                                                                                          
   Affect                                                                                       10.5 (4.2)      11.4 (4.3)      0.2
   Negative symptoms                                                                            8.6 (3.9)       8.7 (3.9)       0.9
   Positive symptoms                                                                            11.1 (4.4)      11.4 (3.3)      0.7
   Resistance                                                                                   7.2 (2.9)       7.6 (2.6)       0.2
   Activation                                                                                   5.8 (2.5)       5.4 (2.6)       0.4
  BPRS total score                                                                              42.8 (11.3)     44.5 (10.2)     0.3
  GAF                                                                                           43.6 (13.2)     43.0 (9.4)      0.8
  SOFAS                                                                                         43.7 (11.6)     43.6 (9.8)      1.0
  Chlorpromazine equivalent (mg/day)                                                            269.4 (222.1)   305.9 (297.9)   0.4

*Summary statistics report means and SDs or percentages*.

*TAU, treatment as usual plus waiting list; MG, treatment as usual plus Michael's game; PDI, Peters delusions inventory; BCIS, Beck cognitive insight scale; MADS, Maudsley assessment of delusions schedule; BPRS, brief psychiatry rating scale; GAF, global assessment of functioning; SOFAS, social and occupational functioning assessment scale*.

Dropouts {#S3-13}
--------

At T2, dropout was associated with treatment allocation (*p* = 0.01). Twenty-three of the TAU group patients and 10 of the MG group patients discontinued the study. At T2, dropout was also associated with younger age (*p* = 0.02). Furthermore, dropouts were more common among patients who dismiss the belief in response to hypothetical contradiction (*p* = 0.04) and those more able to plan a behavioral experiment (*p* = 0.04). There was no other statistically significant difference on the other sociodemographic and clinical characteristics. Dropout at T3 was associated with a younger age (*p* = 0.05) and recruiting centers, where Switzerland had a statistically significant high rate of dropouts during this period compared with the other centers (*p* = 0.01). No other statistically significant difference was observed.

Outcomes {#S3-14}
--------

Table [3](#T3){ref-type="table"} presents patient outcomes at baseline, 3 months, and 9 months for the MG and TAU groups. Figure [2](#F2){ref-type="fig"} depicts the evolution of the PDI conviction raw scores.

###### 

**Evolution of primary and secondary outcome variables by treatment group**.

  Outcome variable                                                                              T1            T2            T3            *p*-Value[^a^](#tfn1){ref-type="table-fn"}^,^[^b^](#tfn2){ref-type="table-fn"}   *p*-Value[^b^](#tfn2){ref-type="table-fn"}^,^[^c^](#tfn3){ref-type="table-fn"}                                                         
  --------------------------------------------------------------------------------------------- ------------- ------------- ------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ------------- --------------------------------------- -----------
  PDI scores                                                                                                                                                                                                                                                                                                                                                      
   Distress                                                                                     21.0 (17.3)   25.3 (16.2)   19.7 (15.3)   20.2 (14.1)                                                                      16.9 (17.0)                                                                      15.1 (12.3)   n.s.[^d^](#tfn4){ref-type="table-fn"}   **0.002**
   Preoccupation                                                                                21.1 (15.8)   23.9 (14.9)   19.6 (13.9)   18.5 (13.2)                                                                      16.9 (14.5)                                                                      14.3 (12.7)   n.s.                                    **0.001**
   Conviction                                                                                   27.0 (18.3)   29.8 (18.4)   24.5 (17.2)   22.4 (15.7)                                                                      21.2 (16.3)                                                                      18.0 (14.3)   **0.005**                               **0.002**
  BCIS score                                                                                                                                                                                                                                                                                                                                                      
   Self-reflectiveness                                                                          14.4 (5.0)    15.1 (4.6)    14.4 (5.0)    16.4 (5.0)                                                                       14.3 (4.3)                                                                       15.4 (4.6)    n.s.                                    n.s.
   Self-certainty                                                                               8.4 (3.1)     8.9 (4.1)     8.2 (3.6)     7.9 (3.8)                                                                        8.3 (3.5)                                                                        7.7 (3.0)     n.s.                                    n.s.
  Anything against the belief                                                                                                                                                                                                                                                                                                                                     
   Yes answers (%)                                                                              38.4          31.4          33.7          48.8                                                                             36.0                                                                             53.5          n.s.                                    **0.001**
  Possibility of being mistaken                                                                                                                                                                                                                                                                                           n.s.                                    n.s.
   Yes answers (%)                                                                              57.0          52.3          54.7          61.6                                                                             51.2                                                                             69.8                                                  
  Response to hypothetical contradiction (%)                                                                                                                                                                                                                                                                              n.s.                                    n.s.
   Dismiss belief                                                                               25.6          12.8          41.9          25.6                                                                             53.5                                                                             36.0                                                  
   Change conviction                                                                            15.1          15.1          9.3           31.4                                                                             8.1                                                                              23.3                                                  
   Accommodate                                                                                  29.1          30.2          19.8          30.2                                                                             19.8                                                                             31.4                                                  
   Ignore or reject                                                                             30.2          41.9          29.1          12.8                                                                             18.6                                                                             9.3                                                   
  Ability to plan a behavioral experiment (%)                                                                                                                                                                                                                                                                             n.s.                                    n.s.
   Able to outline evidence and this outcome logically possible                                 36.0          29.1          51.2          45.3                                                                             61.6                                                                             61.6                                                  
   Able to outline evidence but this outcome logically impossible                               12.8          9.3           10.5          10.5                                                                             7.0                                                                              16.3                                                  
   Unable to outline evidence which would contradict his belief                                 51.2          61.6          38.4          44.2                                                                             31.4                                                                             22.1                                                  
  Awareness of illness (%)                                                                                                                                                                                                                                                                                                n.s.                                    n.s.
   Accept that has a mental illness or nervous problem which includes delusional belief         66.3          52.3          65.1          69.8                                                                             80.2                                                                             79.1                                                  
   Accept that has a mental illness or nervous problem but does not include delusional belief   19.8          30.2          14.0          18.6                                                                             10.5                                                                             12.8                                                  
   Not ill                                                                                      14.0          17.4          20.9          11.6                                                                             9.3                                                                              8.1                                                   
  BPRS score                                                                                                                                                                                                                                                                                                                                                      
   Affect                                                                                       10.7 (4.2)    11.4 (4.3)    10.9 (3.9)    10.5 (4.2)                                                                       11.3 (4.1)                                                                       10.8 (4.0)    n.s.                                    n.s.
   Negative symptoms                                                                            8.4 (3.8)     8.7 (3.9)     9.1 (3.6)     8.1 (3.8)                                                                        8.5 (3.0)                                                                        8.9 (3.9)     n.s.                                    n.s.
   Positive symptoms                                                                            11.1 (4.3)    11.4 (3.3)    10.3 (4.1)    9.8 (4.0)                                                                        10.0 (3.8)                                                                       9.8 (3.8)     n.s.                                    n.s.
   Resistance                                                                                   7.1 (2.9)     7.6 (2.6)     6.3 (2.6)     6.4 (2.6)                                                                        6.6 (2.7)                                                                        6.3 (2.6)     n.s.                                    n.s.
   Activation                                                                                   5.5 (2.4)     5.4 (2.6)     5.4 (2.5)     5.3 (2.6)                                                                        5.5 (2.4)                                                                        5.5 (2.8)     n.s.                                    n.s.
  GAF                                                                                           43.5 (13.0)   43.0 (9.4)    47.5 (11.7)   48.0 (10.5)                                                                      47.0 (11.2)                                                                      48.7 (10.2)   n.s.                                    n.s.
  SOFAS                                                                                         43.8 (11.6)   43.7 (9.8)    47.1 (11.7)   48.4 (10.9)                                                                      46.4 (10.7)                                                                      49.0 (10.0)   n.s.                                    n.s.

*^a^*p*-value resulting from analysis of short-term treatment effect*.

*^b^Only significant results after Bonferroni's correction are reported*.

*^c^*p*-value resulting from analysis of long-term treatment effect*.

*^d^n.s., not significant*.

*Interval variables are reported by their mean and SD \[M (SD)\] and categorical variables by their percentage (%)*.

*TAU, treatment as usual plus waiting list; MG, treatment as usual plus Michael's game; T1, baseline; T2, at 3 months post-treatment; T3, at 6 months follow-up; PDI, Peters delusions inventory; BCIS, Beck cognitive insight scale; BPRS, brief psychiatry rating scale; GAF, global assessment of functioning; SOFAS, social and occupational functioning assessment scale*.

*Bold font indicates significant *p*-value*.

![**Evolution of PDI conviction raw scores by treatment group**.](fpsyt-06-00066-g002){#F2}

### Short-Term Treatment Effect (at T2) on the Primary Outcome {#S3-14-5}

After baseline values, medication, and the cluster effect of center were controlled for, the results of the ANCOVAS showed a short-term treatment effect for conviction (*p* = 0.005). After the intervention, the estimated mean conviction was 29.0 for the TAU group, whereas it was 24.3 for the MG group, which means a short-term treatment effect of −4.7 points (95% CI \[−7.9 to −1.4\]).

### Short-Term Treatment Effect (at T2) on the Secondary Outcomes {#S3-14-6}

No short-term effect was observed for the PDI-21 distress subscale (*p* = 0.1), but an effect was observed for preoccupation (*p* = 0.025), with an estimated mean of 22.3 for the TAU group and 19.0 for the MG group, a treatment effect of −3.3 points (95% CI \[−6.2 to −0.4\]). However, after Bonferroni's correction, this effect was no longer significant.

No short-term treatment effect was observed for either Beck self-reflectiveness (*p* = 0.08) or Beck self-certainty (*p* = 0.4). For BPRS subscores (activation, affect, positive symptoms, and resistance), no treatment effect was found (*p* = 0.6, *p* = 0.3, *p* = 0.4, and *p* = 0.4, respectively). For BPRS negative symptoms, a treatment effect was observed (*p* = 0.019) that was not sustained after Bonferroni's correction. GAF and SOFAS did not exhibit a treatment effect (*p* = 0.1 and *p* = 0.9, respectively). With regard to the MADS items, there was an effect for "anything against the belief" in which the MG group was more likely to answer "yes" than the TAU group (OR = 3.16, 95% CI \[1.30--7.70\], *p* = 0.01). This effect, however, was no longer significant after Bonferroni's correction.

### Long-Term Treatment Effect (at T3) on the Primary Outcome {#S3-14-7}

A sustained effect of the intervention was observed for conviction (*p* = 0.002). At T3, the estimated mean conviction was 24.6 for the TAU group, whereas it was 18.8 for the MG group, a long-term treatment effect of −5.7 points (95% CI \[−9.3 to −2.2\]).

### Long-Term Treatment Effect (at T3) on Secondary Outcomes {#S3-14-8}

A treatment effect was observed for distress, preoccupation, GAF, and SOFAS (*p* = 0.002, *p* = 0.001, *p* = 0.03, and *p* = 0.02, respectively). The mean scores for distress and preoccupation were higher in the TAU group, whereas the mean scores for GAF and SOFAS were higher in the MG group than in the TAU group. However, after Bonferroni's correction, the significance remained only for distress and preoccupation, for which treatment effects were estimated at −5.5 points (95% CI \[−9.0 to −2.0\]) and −5.5 points (95% CI \[−8.6 to −2.2\]), respectively.

Regarding MADS variables, a sustained treatment effect was observed only for "anything against the belief": the MG group was more likely to answer "yes" than the TAU group (OR = 4.95, 95% CI \[1.85--13.27\], *p* = 0.001). This effect remained significant after Bonferroni's correction.

Discussion {#S4}
==========

This study investigated the effects of a hypothetical reasoning training module of short duration, called MG, in a sample of 172 outpatients with psychotic symptoms in 16 centers in France, Italy, Monaco, and Switzerland. In accord with the main hypothesis, the conviction score measured with the PDI-21 was improved in the MG condition compared with the TAU condition at T2, the post-intervention assessment. After Bonferroni's correction, no other effects on the secondary outcomes were observed at post-intervention.

Six months later, the effect observed on the conviction score of the PDI-21 was sustained. Furthermore, other effects were observed, after Bonferroni's correction, on the distress and preoccupation subscales of the PDI-21. In addition, these results in the MG group were supplemented with an improvement in belief flexibility, as measured with the MADS item "anything against the belief."

The results do not show specific effects on the BPRS scale. The observed effects occurred on more detailed measures such as the conviction subscale of the PDI-21 (the main outcome), the distress and preoccupation subscales of the PDI-21, and one of the MADS items. This pattern possibly indicates that MG increases belief flexibility and changes the relation of the participants to their symptoms to some extent. As suggested elsewhere ([@B19]), the effect of CBT on psychotic disorders is probably of more interest for outcomes such as distress, preoccupation, and conviction related to beliefs than it is for psychotic symptoms as measured by the BPRS. Indeed, through specific training on hypothetical reasoning, MG seems to promote other viewpoints about what happens (as suggested by the observed changes on the PDI-21 and on the MADS), which is considered particularly helpful to patients dealing with stressful positive symptoms ([@B9]).

In the present study, as reported in a number of other studies on psychotherapy ([@B36]--[@B43]), post-intervention effects were sustained at follow-up on the primary outcome. The further improvements observed at follow-up on some outcomes possibly suggests that the effect of the intervention fosters additional changes. One may hypothesize that the first improvements on conviction and the patient's possible appropriation of the model of reasoning with hypotheses may allow additional experiences in daily life, and then improvements for at least some patients, as suggested by a previous case report ([@B44]). Future studies are needed, however, in order to assess the process that may be involved in such supposed effects.

One can also hypothesize that the game could be used as a warm-up program before applying it to an individualized CBT intervention for psychosis. The fidelity checks indicate good fidelity to the intervention in the assessed centers. These results show that an easy-to-use program such as MG may facilitate the dissemination of CBT (specifically hypothetical reasoning training) for psychosis in natural settings. The game may also familiarize health care professionals with the use of CBT techniques for psychosis. This of particularly high interest in consideration of the scarcity of psychotherapeutic treatments offered in clinical settings for people with psychotic disorders ([@B16], [@B17], [@B45]).

Dropout was relatively low. The game format may increase therapeutic alliance, a possible mediating factor of treatment outcomes in patients with psychosis ([@B46]). This aspect was not studied in the present paper, however, and may merit further studies. Dropout at T2 was associated with variables such as a younger age and a higher percentage of participants who dismissed the belief in response to a hypothetical contradiction. These patients possibly perceived less utility in the game than other patients did. The dropout rate associated with younger participants is in accordance with other observations ([@B47]) and suggests that the module could be improved to better engage them in the intervention or could be completed with other recovery-oriented interventions and psycho-education ([@B20], [@B48]).

In the absence of an active control group in our study, we cannot exclude the possibility that the observed effects were due to non-specific psychotherapeutic effects such as non-specific attention and interactions with the game leaders and other patients ([@B45], [@B49]). In addition, the absence of audiotaped sessions in some centers to control for fidelity to the intervention by group leaders may have missed poor fidelity in some centers. The lack of precise comparison of the TAU components in the 16 centers may have influenced the results. However, the analyses were controlled for center to correct for a possible cluster effect.

The multicentre design of the study may increase the possible generalization of the results. Furthermore, as reported in other studies ([@B50]), the limited number of exclusion criteria could contribute to the external validity of the study. We cannot fully rule out the influence of factors such as comorbid disorders (i.e., substance use disorders) or variations in cognitive deficits on the treatment outcomes.

Conclusion {#S5}
==========

The results of this study indicate that the use of MG, a hypothetical reasoning training module, may improve belief flexibility and self-assessment of delusion in patients with psychotic disorders in comparison with not using it. MG appears to be a short and easy-to-use intervention to disseminate CBT for psychosis in routine clinical settings. Further studies with active control group are still needed to improve the understanding of the possible effect of the game.
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